Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions

Lung Cancer

Volumn 102, Issue , 2016, Pages 89-95

  Lee, Sang Hoon ^a   Sung, Ji Yeon ^b   Yong, Dongeun ^b   Chun, Jongsik ^c,d   Kim, Song Yee ^b   Song, Joo Han ^b   Chung, Kyung Soo ^b   Kim, Eun Young ^b   Jung, Ji Ye ^b   Kang, Young Ae ^b   Kim, Young Sam ^b   Kim, Se Kyu ^b   Chang, Joon ^b   Park, Moo Suk ^b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Seoul National University   (South Korea)

^d ChunLab Inc   (South Korea)

Author keywords

Benign mass; Bronchoalveolar fluid; Lung cancer; Microbiome; New generation sequencing

Indexed keywords

RNA 16S; BIOLOGICAL MARKER;

ADULT; ARTICLE; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CANCER PATIENT; CLINICAL ARTICLE; FEMALE; FIRMICUTES; HUMAN; LUNG CANCER; LUNG LESION; MALE; MEGASPHAERA; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; PROSPECTIVE STUDY; VEILLONELLA; AGED; COMPARATIVE STUDY; GENETICS; HIGH THROUGHPUT SEQUENCING; ISOLATION AND PURIFICATION; LUNG TUMOR; METABOLISM; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; NEOPLASM; PROCEDURES;

AGED; BIOMARKERS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LUNG NEOPLASMS; MALE; MEGASPHAERA; MICROBIOTA; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; RNA, RIBOSOMAL, 16S; VEILLONELLA;

EID: 84994741661     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2016.10.016     Document Type: Article

References (26)

1. [1] Marsland, B.J., Yadava, K., Nicod, L.P., The airway microbiome and disease. Chest 144 (2013), 632–637.
2. [2] Hilty, M., Burke, C., Pedro, H., Cardenas, P., Bush, A., Bossley, C., et al. Disordered microbial communities in asthmatic airways. PLoS One, 5, 2010, e8578.
3. [3] Islami, F., Torre, L.A., Jemal, A., Global trends of lung cancer mortality and smoking prevalence. Transl. Lung Cancer Res. 4 (2015), 327–338.
4. [4] Xia, Y., Zhang, B., Zhang, H., Li, W., Wang, K.P., Shen, H., Evaluation of lymph node metastasis in lung cancer: who is the chief justice. J. Thorac. Dis. 7 (2015), S231–7.
5. [5] Borghaei, H., Paz-Ares, L., Horn, L., Spigel, D.R., Steins, M., Ready, N.E., et al. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N. Engl. J. Med. 373 (2015), 1627–1639.
6. [6] Sequist, L.V., Soria, J.C., Goldman, J.W., Wakelee, H.A., Gadgeel, S.M., Varga, A., et al. Rociletinib in EGFR-mutated non-small-cell lung cancer. N. Engl. J. Med. 372 (2015), 1700–1709.
7. [7] Solomon, B.J., Mok, T., Kim, D.W., Wu, Y.L., Nakagawa, K., Mekhail, T., et al. First-line crizotinib versus chemotherapy in ALK-positive lung cancer. N. Engl. J. Med. 371 (2014), 2167–2177.
8. [8] Koskela, P., Anttila, T., Bjorge, T., Brunsvig, A., Dillner, J., Hakama, M., et al. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int. J. Cancer 85 (2000), 35–39.
9. [9] An international association between Helicobacter pylori infection and gastric cancer. The EUROGAST Study Group. Lancet 341 (1993), 1359–1362.
10. [10] Bosch, F.X., Manos, M.M., Munoz, N., Sherman, M., Jansen, A.M., Peto, J., et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective: international biological study on cervical cancer (IBSCC) Study Group. J. Natl. Cancer Inst. 87 (1995), 796–802.
11. [11] Brenner, D.R., McLaughlin, J.R., Hung, R.J., Previous lung diseases and lung cancer risk: a systematic review and meta-analysis. PLoS One, 6, 2011, e17479.
12. [12] Meyer, M.S., Joshipura, K., Giovannucci, E., Michaud, D.S., A review of the relationship between tooth loss, periodontal disease, and cancer. Cancer Causes Control 19 (2008), 895–907.
13. [13] Hosgood, H.D. 3rd, Sapkota, A.R., Rothman, N., Rohan, T., Hu, W., Xu, J., et al. The potential role of lung microbiota in lung cancer attributed to household coal burning exposures. Environ. Mol. Mutagen. 55 (2014), 643–651.
14. [14] Gui, Q.F., Lu, H.F., Zhang, C.X., Xu, Z.R., Yang, Y.H., Well-balanced commensal microbiota contributes to anti-cancer response in a lung cancer mouse model. Genet. Mol. Res. 14 (2015), 5642–5651.
15. [15] Huber, T., Faulkner, G., Hugenholtz, P., Bellerophon: a program to detect chimeric sequences in multiple sequence alignments. Bioinformatics 20 (2004), 2317–2319.
16. [16] Kim, O.S., Cho, Y.J., Lee, K., Yoon, S.H., Kim, M., Na, H., et al. Introducing EzTaxon-e: a prokaryotic 16S rRNA gene sequence database with phylotypes that represent uncultured species. Int. J. Syst. Evol. Microbiol. 62 (2012), 716–721.
17. [17] Hamady, M., Lozupone, C., Knight, R., Fast UniFrac: facilitating high-throughput phylogenetic analyses of microbial communities including analysis of pyrosequencing and PhyloChip data. ISME J. 4 (2010), 17–27.
18. [18] Blainey, P.C., Milla, C.E., Cornfield, D.N., Quake, S.R., Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis. Sci. Transl. Med., 4, 2012, 153ra30.
19. [19] Marsland, B.J., Trompette, A., Gollwitzer, E.S., The gut-lung axis in respiratory disease. Ann. Am. Thorac. Soc. 12:Suppl. 2 (2015), S150–6.
20. [20] Yang, Y., Dong, J., Sun, K., Zhao, L., Zhao, F., Wang, L., et al. Obesity and incidence of lung cancer: a meta-analysis. Int. J. Cancer 132 (2013), 1162–1169.
21. [21] Blaut, M., Klaus, S., Intestinal microbiota and obesity. Handb. Exp. Pharmacol., 2012, 251–273.
22. [22] Kolak, M., Karpati, F., Monstein, H.J., Jonasson, J., Molecular typing of the bacterial flora in sputum of cystic fibrosis patients. Int. J. Med. Microbiol. 293 (2003), 309–317.
23. [23] Sze, M.A., Dimitriu, P.A., Hayashi, S., Elliott, W.M., McDonough, J.E., Gosselink, J.V., et al. The lung tissue microbiome in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 185 (2012), 1073–1080.
24. [24] Pragman, A.A., Kim, H.B., Reilly, C.S., Wendt, C., Isaacson, R.E., The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PLoS One, 7, 2012, e47305.
25. [25] Wang, H., Yang, L., Zou, L., Huang, D., Guo, Y., Pan, M., et al. Association between chronic obstructive pulmonary disease and lung cancer: a case-control study in Southern Chinese and a meta-analysis. PLoS One, 7, 2012, e46144.
26. [26] Yan, X., Yang, M., Liu, J., Gao, R., Hu, J., Li, J., et al. Discovery and validation of potential bacterial biomarkers for lung cancer. Am. J. Cancer. Res. 5 (2015), 3111–3122.